The African Medicines Agency (AMA) has been launched in Kigali, Rwanda, to address the challenges of ensuring quality-assured medicines can reach patients across national borders without unnecessary regulatory delays. Africa imports over 70% of its medicines and almost all its vaccines, leaving the continent dependent on external suppliers. The AMA aims to close the gap in Africa's health system by providing a continental regulatory framework capable of strengthening confidence in medicines.
Dr. Michel Sidibé, the African Union Special Envoy for AMA, believes the agency fills a critical gap in Africa's health system. He stated that fragmented national systems make it harder for locally manufactured products to reach patients across the continent. A more coordinated system could allow regulators to share scientific assessments, reduce duplication, and help quality-assured products reach more markets.
The problem is not only that countries have different rules, but also that their regulatory institutions have different levels of technical capacity, expertise, and resources. Experts say the solution lies in building credible national systems while enabling authorities to rely on assessments conducted by trusted counterparts. Shared assessments could significantly shorten the time it takes for products to reach patients.
Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), said that fragmented regulatory systems can delay access to medicines, increase costs, and weaken countries' ability to respond to health threats. The WHO is working with AMA to strengthen national regulatory authorities and advance regulatory convergence, including through shared assessments and reliance on work undertaken by trusted agencies.
Rwanda's Minister of State for Health, Dr. Yvan Butera, emphasized the importance of confidence in the quality and safety of medicines. He argued that stronger cooperation between regulators can extend protection across borders, helping ensure that patients benefit from reliable oversight regardless of where they live.
Two hubs have been launched in Rwanda to turn the continental ambition into practical work: the Capacity Strengthening hub and the Regulatory Innovation and Manufacturing Readiness hub. Prof. Paul Lalvani, Executive Director of Empower School of Health, said that their significance lies in addressing the shortage of people and institutions capable of operating effectively.
The ultimate measure of success should be whether Africa becomes less dependent on imported medical products. Specialists say that the real metric is how self-reliant Africa is when it comes to local manufacturing of pharmaceuticals, vaccines, medical devices, and medical diagnostics. The African Continental Free Trade Area, stronger national regulators, and AMA could reinforce one another by establishing improved regulatory capacity and support product quality.
Key points
- The African Medicines Agency aims to streamline regulatory processes to ensure quality-assured medicines can reach patients across national borders.
- Fragmented regulatory systems can delay access to medicines, increase costs, and weaken countries' ability to respond to health threats.
- The ultimate measure of success is whether Africa becomes less dependent on imported medical products.
